Psychoneurobics Therapy In Treatment Of Irritable Bowel Syndrome Or Irritable Bowel Disease


  • Bhumika Berry
  • Dr. Mahesh Dogra


Psychoneurobics Therapy, Irritable Bowel Syndrome or Irritable Bowel Disease (IBS or IBD), Manipura (Navel) Chakra, Swadhisthana (Spleen) Chakra, Agni Mudra (Joyful Neurobics), Varun Mudra (Purifying Neurobics)


The present study was conducted on a group of 100 patients suffering from Irritable Bowel Syndrome or Irritable Bowel Disease (IBS or IBD). The patients had varied Gastrointestinal Tract Symptoms. These included loose stool (diarrhea), abdominal pain, appetite variation, abnormality in stools passed out like presence of blood etc., abnormalities in characteristics as far as quality and quantity of stool is concerned etc. Many patients also had mental abnormalities because of this highly discomfortable disease. Now these patients were treated using an emerging scientific/ medical therapy based on the chakras present in the human body; by virtue of magnificent Nature. The Chakras/Plexuses involved in this therapy included: Manipura (Navel) Chakra/Solar Plexus and Swadhisthana (Spleen) Chakra/Sacral Plexus. These are assosciated with Agni Mudra (Joyful Neurobics) and Varun Mudra (Purifying Neurobics) respectively. Each Patient was treated individually in a mildly lit small room or cabin with Yellow/Orange Light (colours assosciated with these two involved Chakras).They were further guided to visualize 3rd Eye Healing Album - Concentrate & Cure or Health Management Kit- 3d Plates.  Daily session was conducted which lasted for 20-30 minutes. Regarding duration of undergoing through psychoneurobics therapy; 32% had done so for 7-9 months, 33% for 4-6 months, 20% for 10-12 months and remaining 15% had undergone for 1-3 months. 41% patients had full relief, 32% reported mild relief and 22% informed to have moderate relief. Thereby we conclude that Psychoneurobics Therapy can cure IBD / IBS significantly.


Wang GF, Ren JA, Liu S, Chen J, (July 2012). "Clinical characteristics of non-perianal fistulating Crohn’s disease in China: a single-center experience of 184 cases". Chinese Medical Journal. 125 (14): 2405–10. PMID 22882911.

Stein J, Hartmann F, Dignass AU (November 2010). "Diagnosis and management of iron deficiency anemia in patients with IBD”. Nature Reviews. Gastroenterology & Hepatology. 7 (11): 599–610. doi:10.1038/nrgastro.2010.151. PMID 20924367.

Lu DG, Ji XQ, Liu X, Li HJ, Zhang CQ (January 2014). "Pulmonary manifestations of Crohn's disease". World Journal of Gastroenterology. 20 (1): 133–41. doi:10.3748/wjg.v20.i1.133. PMC 3886002. PMID 24415866.

Rashvand S, Behrooz M, Samsamikor M, Jacobson K, Hekmatdoost A (June 2018). "Dietary patterns and risk of ulcerative colitis: a case-control study". Journal of Human Nutrition and Dietetics. 31 (3): 408–412. doi:10.1111/jhn.12544. PMID 29468761.

Andersen V, Olsen A, Carbonnel F, Tjønneland A, Vogel U (March 2012). "Diet and risk of inflammatory bowel disease". Digestive and Liver Disease. 44 (3): 185–94. doi:10.1016/j.dld.2011.10.001. PMID 22055893.

Kotanko P, Carter M, Levin NW (August 2006). "Intestinal bacterial microflora--a potential source of chronic inflammation in patients with chronic kidney disease". Nephrology, Dialysis, Transplantation. 21 (8): 2057–60. doi:10.1093/ndt/gfl281. PMID 16762961.

Cario E (September 2010). "Toll-like receptors in inflammatory bowel diseases: a decade later". Inflammatory Bowel Diseases. 16 (9): 1583–97. doi:10.1002/ibd.21282. PMC 2958454. PMID 20803699.

Jostins L, Ripke S, Weersma RK, 2012). "Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease". Nature. 491 (7422): 119–24. Bibcode:2012Natur.491..119.. doi:10.1038/nature11582. PMC 3491803. PMID 23128233.

Chu, Hiutung; Khosravi, Arya; Kusumawardhani, Indah P.; Kwon, Alice H. K.; Vasconcelos, Anilton C.; Cunha, Larissa D.; Mayer, Anne E.; Shen, Yue; Wu, Wei-Li (2016-05-27). "Gene-microbiota interactions contribute to the pathogenesis of inflammatory bowel disease". Science. 352 (6289): 1116–1120. Bibcode:2016Sci...352.1116C. doi:10.1126/science.aad9948. ISSN 1095-9203. PMC 4996125. PMID 27230380.

Cappello, Maria; Randazzo, Claudia; Bravatà, (2014). "Liver Function Test Abnormalities in Patients with Inflammatory Bowel Diseases: A Hospital-based Survey". Clinical Medicine Insights: Gastroenterology. 7: 25–31. doi:10.4137/CGast.S13125. ISSN 1179-5522. PMC 4069044. PMID 24966712.

Karimuddin A, Gilles G. "Surgery for Abdominal/Intestinal Crohn's Disease". Trusted Therapies. Trusted Therapies. Retrieved 19 May 2015.

D’Haens GR, Panaccione R, Higgins PD, 2011). "The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response?". The American Journal of Gastroenterology. 106 (2): 199–212, quiz 213. doi:10.1038/ajg.2010.392. PMID 21045814.

Charlebois A, Rosenfeld G, Bressler B (June 2016). "The Impact of Dietary Interventions on the Symptoms of Inflammatory Bowel Disease: A Systematic Review". Critical Reviews in Food Science and Nutrition. 56 (8): 1370–8. doi:10.1080/10408398.2012.760515. PMID 25569442.

Liu S, Ren J, Hong Z, Yan D, Gu G, Han G, Wang G, Ren H, Chen J, Li J (February 2013). "Efficacy of erythropoietin combined with enteral nutrition for the treatment of anemia in Crohn's disease: a prospective cohort study". Nutrition in Clinical Practice. 28 (1): 120–7. doi:10.1177/0884533612462744. PMID 23064018.

Jump up to:a b Colman RJ, Rubin DT (December 2014). "Fecal microbiota transplantation as therapy for inflammatory bowel disease: a systematic review and meta-analysis". Journal of Crohn's & Colitis. 8 (12): 1569–81. doi:10.1016/j.crohns.2014.08.006. PMC 4296742. PMID 25223604.

Gilardi D, Fiorino G, Genua M, Allocca M, Danese S (September 2014). "Complementary and alternative medicine in inflammatory bowel diseases: what is the future in the field of herbal medicine?". Expert Review of Gastroenterology & Hepatology. 8 (7): 835–46. doi:10.1586/17474124.2014.917954. PMID 24813226.




How to Cite

Bhumika Berry, & Dr. Mahesh Dogra. (2020). Psychoneurobics Therapy In Treatment Of Irritable Bowel Syndrome Or Irritable Bowel Disease. Research Inspiration: An International Multidisciplinary E-Journal, 6(I), 01–09. Retrieved from